C.Surgical Procedure; Cardiac Clinical Trial
Official title:
Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery: a Randomized and Prospective Clinical Trial
The purpose of this study is evaluate goal-directed therapy with continuous central venous saturation compared to standard therapy in children undergoing cardiac surgery.
Pediatric patients undergoing cardiac surgery are at risk for adverse clinical outcomes due a inadequate tissue perfusion. Recent studies have been demonstraded which the monitorization of continuos central venous saturation could be benneficial. There is evidence that monitoring continues venous oxygen saturation (ScvO2) can be beneficial in patient outcomes, guided by ScvO2 therapy has been associated with improved outcomes in resuscitation of critically ill patients with sepsis and after congenital heart surgery complexa. The early detection and treatment of tissue hypoxia can prevent morbidity and mortality. tissue hypoxia may be a result of the imbalance between supply (DO2) and oxygen consumption (VO2). If the fault supply, oxygen consumption is maintained by increased oxygen extraction resulting in decreased central venous oxygen saturation ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02908009 -
A Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery
|
||
Completed |
NCT01998438 -
Prospective Trial of Tranexamic Acid in Cardiac Surgery
|
Phase 4 | |
Completed |
NCT01805466 -
Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO)
|
N/A | |
Completed |
NCT02658006 -
Evaluation of Monitoring TECHNOlogies in the PERI-OPerative Care of Cardiac Surgical Patients
|
N/A | |
Completed |
NCT02571920 -
Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA)
|
N/A | |
Completed |
NCT02267538 -
Dexmedetomidine and Delirium in Patients After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT02866825 -
Studying Complement Inhibition in Complex Cardiac Surgery
|
Phase 2 | |
Completed |
NCT02513862 -
Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery
|
N/A | |
Completed |
NCT02560519 -
Albumin in Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT03884725 -
Fibrinogen Concentrate In Children Cardiac Surgery 2
|
Phase 4 | |
Recruiting |
NCT01879475 -
Safety and Performance of 032-11 Haemostat in Cardiac and Thoracic Aortic Surgery
|
N/A | |
Completed |
NCT00598195 -
Ketamine Pharmacokinetics in Children Having Heart Surgery
|
N/A | |
Completed |
NCT02972684 -
Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass
|
N/A | |
Recruiting |
NCT02560285 -
High-risk Patients in Cardiac Surgery Procedures: HiriSCORE
|
N/A | |
Terminated |
NCT02793895 -
Detection of Atrial Fibrillation After Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT03343418 -
Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery
|
Phase 4 | |
Recruiting |
NCT03882593 -
Blood Cell Adhesion to Arterial Filters During Cardiac Surgery
|
||
Withdrawn |
NCT02119806 -
Decreasing the Incidence of Delirium After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT02831907 -
Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Recruiting |
NCT02745951 -
HELIox CardiOPlegia Trial During Cardiac surgERy
|
N/A |